M&A Deal Summary

Concentra Biosciences Acquires iTeos Therapeutics

On July 21, 2025, Concentra Biosciences acquired life science company iTeos Therapeutics for 475M USD

Acquisition Highlights

This is Concentra Biosciences’ 7th transaction in the Life Science sector.
This is Concentra Biosciences’ largest (disclosed) transaction.
This is Concentra Biosciences’ 7th transaction in the United States.
This is Concentra Biosciences’ 3rd transaction in Massachusetts.

M&A Deal Summary
Date	2025-07-21
Target	iTeos Therapeutics
Sector	Life Science
Buyer(s)	Concentra Biosciences
Deal Type	Add-on Acquisition
Deal Value	475M USD

Target

iTeos Therapeutics

Watertown, Massachusetts, United States

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of the tumor microenvironment and immunosuppressive pathways to design novel product candidates with an aim to improve the clinical benefit of oncology therapies. iTeos Therapeutics was founded in 2011 and is based in Watertown, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try Free

Buyer(S) 1

Buyer